TRAEs ≥G3 in one or more patients included neutropenia (G3, 12 (34.3%); G4, 2 (5.7%)), leukopenia (G3, 4 (11.4%)) and anemia (G3, 3 (8.6%)) and increase in ALT (G3, 2 (5.7%)) (Table 2). The gene discussed is GPT; the disease is anemia (phenotype).